PUBLIC COMPANY
saveCORXEL Pharmaceuticals (Shanghai) Co Ltd
updated 2mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets
- phase2A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- phase3Optimizing Reperfusion to Improve Outcomes and Neurologic Function
- phase3An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM
- phase2A Study to Evaluate the Efficacy and Safety of CX11 Tablets in Overweight/Obese Participants
- phase3Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia
- phase1Safety, Tolerability and Pharmacokinetics Study of CK-3773274
- phase3Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that